SAGE-217 reduces depressive symptoms in patients with major depression within 2...

1. Patients with major depression randomized to receive SAGE-217, a positive allosteric modulator of γ-aminobutyric acid (GABA) type A receptors, experienced fewer depressive symptoms...

2 Minute Medicine Rewind September 9, 2019

Prehospital Stroke Management Optimized by Use of Clinical Scoring vs Mobile Stroke Unit for Triage of Patients with Stroke: A Randomized Clinical TrialThe effective...
licensing as small

All-time hits